Recalcitrant cutaneous sarcoidosis responding to infliximab

Arch Dermatol. 2005 Jul;141(7):910-1. doi: 10.1001/archderm.141.7.910.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Follow-Up Studies
  • Humans
  • Infliximab
  • Infusions, Intravenous
  • Middle Aged
  • Sarcoidosis / diagnosis
  • Sarcoidosis / drug therapy*
  • Severity of Illness Index
  • Skin Diseases / diagnosis
  • Skin Diseases / drug therapy*
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Infliximab